ANTRIL

Welcome to the Brand page for “ANTRIL”, which is offered here for Pharmaceuticals, including protein-based and other pharmaceuticals for use in treating diseases, including inflammatory diseases, chronic skin ulcers, neurological disorders, rheumatoid arthritis, sepsis and septic shock, leukemia, cystic fibrosis, genetic emphysema and peripheral neuropathies, sepsis syndrome; systemic inflammatory response syndrome ( sirs) due to sepsis; pancreatitis; burns and cachexia; asthma; inflammatory bowel disease; graft versus host disease; and stroke; il-1 mediated diseases;.

Its status is currently believed to be active. Its class is unavailable. “ANTRIL” is believed to be currently owned by “Synergen, Inc.”